Tamborlane WV - Search Results

1

Liraglutide in Children and Adolescents with Type 2 Diabetes.

Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.

2

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.

Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Sinha R, et al. Among authors: tamborlane wv. N Engl J Med. 2002 Mar 14;346(11):802-10. doi: 10.1056/NEJMoa012578. N Engl J Med. 2002. PMID: 11893791 Free article.

3

Obesity and the metabolic syndrome in children and adolescents.

Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Weiss R, et al. Among authors: tamborlane wv. N Engl J Med. 2004 Jun 3;350(23):2362-74. doi: 10.1056/NEJMoa031049. N Engl J Med. 2004. PMID: 15175438 Free article.

4

Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies.

Weinzimer SA, Doyle EA, Tamborlane WV Jr. Weinzimer SA, et al. Among authors: tamborlane wv jr. Clin Pediatr (Phila). 2005 Jun;44(5):393-403. doi: 10.1177/000992280504400503. Clin Pediatr (Phila). 2005. PMID: 15965545 Review.

5

Insulin pump treatment of childhood type 1 diabetes.

Weinzimer SA, Sikes KA, Steffen AT, Tamborlane WV. Weinzimer SA, et al. Among authors: tamborlane wv. Pediatr Clin North Am. 2005 Dec;52(6):1677-88. doi: 10.1016/j.pcl.2005.07.004. Pediatr Clin North Am. 2005. PMID: 16301088

6

Diabetes in overweight pediatric patients.

Tamborlane WV. Tamborlane WV. Clin Cornerstone. 2005;7 Suppl 3:S25-9. doi: 10.1016/s1098-3597(05)80086-9. Clin Cornerstone. 2005. PMID: 16545735

7

Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment.

Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, Weinzimer SA. Springer D, et al. Among authors: tamborlane wv. J Pediatr. 2006 Aug;149(2):227-32. doi: 10.1016/j.jpeds.2006.03.052. J Pediatr. 2006. PMID: 16887440

8

Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.

Tamborlane WV, Sikes KA, Steffen AT, Weinzimer SA. Tamborlane WV, et al. Diabetes Res Clin Pract. 2006 Dec;74 Suppl 2:S112-5. doi: 10.1016/S0168-8227(06)70011-0. Diabetes Res Clin Pract. 2006. PMID: 17182301

9

Past, present, and future of insulin pump therapy: better shot at diabetes control.

Sherr J, Tamborlane WV. Sherr J, et al. Among authors: tamborlane wv. Mt Sinai J Med. 2008 Aug;75(4):352-61. doi: 10.1002/msj.20055. Mt Sinai J Med. 2008. PMID: 18729180 Free PMC article. Review.

10

Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.

Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, Tamborlane WV, Caprio S. Burgert TS, et al. Among authors: tamborlane wv. Pediatr Diabetes. 2008 Dec;9(6):567-76. doi: 10.1111/j.1399-5448.2008.00434.x. Epub 2008 Aug 27. Pediatr Diabetes. 2008. PMID: 18761646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page